PRWeb News Wire. 2009. Radiopharmaceuticals Market in US and Europe to reach $5.4 Billion by 2015, According to New Report by Global Industry Analysts. PRWeb News Wire, February 18, 2009 [online]. Available: http://www.prweb.com/releases/radiopharmaceuticals/diagnostic_therapeutic/prweb2080594.htm [accessed November 7, 2011].
PRWeb News Wire. 2010. Global Nuclear Medicine Market to Reach US $1.69 Billion by 2015, According to New Report by Global Industry Analysts, Inc. PRWeb News Wire, October 21, 2010 [online]. Available: http://www.prweb.com/releases/nuclear_medicine_PET/scanners_gamma_cameras/prweb4677724.htm [accessed November 7, 2011].
Rowe, C. C., U. Ackerman, W. Browne, R. Mulligan, K. L. Pike, G. O’Keefe, H. Tochon-Danguy, G. Chan, S. U. Berlangieri, G. Jones, K. L. Dickinson-Rowe, H. P. Kung, W. Zhang, M. P. Kung, D. Skovronsky, T. Dyrks, G. Holl, S. Krause, M. Friebe, L. Lehman, S. Lindemann, L. M. Dinkelborg, C. L. Masters, and V. L. Villemagne. 2008. Imaging of amyloid beta in Alzheimer’s disease with 18F-BAY94-9172, a novel PET tracer: Proof of mechanism. Lancet Neurol 7(2):129-135.
Seidlin, S., L. D. Marinelli, and E. Oshry. 1946. Radioactive iodine therapy: Effect on functioning metastases of adenocarcinoma of the thyroid. JAMA 132(14):838-847.
Unterweger, M. P., D. D. Hoppes, F. J. Schima, and J. S. Coursey. 2010. Radionuclide Half-Life Measurements. The National Institute of Standards and Technology [online]. Available: http://www.nist.gov/pml/data/halflife-html.cfm [accessed November 10, 2011].
Wadas, T. J., E. H. Wong, G. R. Weisman, and C. J. Anderson. 2010. Coordinating radiometals of copper, gallium, indium, yttrium and zirconium for PET and SPECT imaging of disease. Chem. Rev. 110(5):2858-2902.
Wong, D. F., P. B. Rosenberg, Y. Zhou, A. Kumar, V. Raymont, H. T. Ravert, R. F. Dannals, A. Nandi, J. R. Brasiæ, W. Ye, J. Hilton, C. Lyketsos, H. F. Kung, A. D. Joshi, D. M. Skovronsky, and M. J. Pontecorvo. 2010. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med 51(6):913-920.